JP Morgan day 2: Big Pharma hunts outside assets to boost pipelines
This article was originally published in Scrip
Executive Summary
Big Pharma executives took to the stage on day two of the 31st Annual JP Morgan Healthcare Conference on 8 January in San Francisco to talk about how they plan to grow in the face of expired blockbuster drug patents and other challenges, mainly by building up their pipelines through internal research and development, partnerships and acquisitions.